March 31, 2025 - 23:42

SAN FRANCISCO, March 31, 2025—Anrok, a prominent tax compliance platform, has unveiled a significant expansion aimed at streamlining tax compliance for businesses dealing with physical goods. This development marks a pivotal shift as the company extends its services beyond digital offerings, responding to the increasing demand for automation in tax processes for tangible products.
The decision to broaden the platform's capabilities aligns with the growing trend of investment in physical infrastructure, spurred by advancements in artificial intelligence. As the lines between digital and physical commerce continue to blur, Anrok's new features will empower businesses to navigate the complexities of tax compliance more efficiently.
With this enhancement, Anrok aims to support a diverse range of industries that are experiencing rapid growth due to technological innovations. By automating tax compliance for physical goods, the platform positions itself as a vital resource for companies looking to thrive in an evolving marketplace, ensuring they remain compliant while focusing on their core operations.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...